BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.06
Delayed Data
As of 4:00pm ET
 +0.10 / +2.02%
Today’s Change
3.95
Today|||52-Week Range
9.25
+3.05%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close4.96
Today’s open4.93
Day’s range4.93 - 5.16
Volume1,348,590
Average volume (3 months)1,215,291
Market cap$488.1M
Data as of 4:00pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)-27.12%
Earnings growth (this year)+5.71%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-45.39%
P/E ratioNM
Price/Sales17.70
Price/Book231.88

Competitors

 Today’s
change
Today’s
% change
MRSNMersana Therapeutics...-0.56-3.65%
CYADCelyad SA-0.54-1.29%
SELBSelecta Biosciences ...+0.31+3.65%
NSTGNanoString Technolog...-0.18-2.57%
Data as of 4:00pm ET, 02/20/2018

Financials

Last reporting dateFebruary 20, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$26.4M
Annual profit (last year)-$55.1M
Net profit margin-209.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts